MCID: PLC008
MIFTS: 61

Placenta Disease

Categories: Rare diseases, Fetal diseases

Aliases & Classifications for Placenta Disease

Summaries for Placenta Disease

Disease Ontology : 12 A uterine disease that is located in the placenta.

MalaCards based summary : Placenta Disease, also known as pregnancy complications, is related to placental insufficiency and antiphospholipid syndrome, and has symptoms including morning sickness, hyperemesis gravidarum and late pregnancy bleeding. An important gene associated with Placenta Disease is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways/superpathways are Regulation of IFNA signaling and IL-1 Family Signaling Pathways. The drugs Zinc and Copper have been mentioned in the context of this disorder. Affiliated tissues include the placenta, placenta and testes, and related phenotypes are Increased shRNA abundance and cardiovascular system

Wikipedia : 76 Ischemic placental disease leads to the attachment of the placenta to the uterine wall to become... more...

Related Diseases for Placenta Disease

Diseases related to Placenta Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 197)
# Related Disease Score Top Affiliating Genes
1 placental insufficiency 32.3 AFP F3 PGF
2 antiphospholipid syndrome 32.0 APOH F3 F5 MTHFR SERPINC1
3 placenta praevia 31.8 EPHA1 HADHA SERPINH1
4 placental abruption 31.7 APOH F5 MTHFR PGF SERPINC1
5 hellp syndrome 30.8 APOH F3 F5 HADHA IL6 MTHFR
6 thrombophilia 30.3 APOH F3 F5 MTHFR SERPINC1
7 chorioamnionitis 30.1 CXCL8 IL1B IL6 OXT
8 eclampsia 28.7 F5 MTHFR OXT PAPPA PGF SERPINC1
9 pre-eclampsia 26.5 AFP APOH F3 F5 HADHA IL6
10 inferior vena cava interruption 11.0 F5 MTHFR
11 may-thurner syndrome 11.0 APOH F5
12 acanthamoeba keratitis 11.0 APOH F5
13 amaurosis fugax 11.0 F5 MTHFR
14 mixed germ cell tumor 10.9 AFP CGB3
15 acquired hemophilia a 10.8 F3 F5
16 livedoid vasculopathy 10.8 APOH F5 MTHFR
17 osteoporotic fracture 10.8 IL6 MTHFR
18 tuberculous epididymitis 10.8 AFP CGB3
19 patent foramen ovale 10.8 F5 MTHFR SERPINC1
20 protein c deficiency 10.8 F5 MTHFR SERPINC1
21 intestinal impaction 10.8 F3 SERPINC1
22 nonarteritic anterior ischemic optic neuropathy 10.8 F5 MTHFR SERPINC1
23 prothrombin deficiency, congenital 10.8 APOH F5 SERPINC1
24 fournier gangrene 10.8 F3 SERPINC1
25 oligohydramnios 10.8
26 placenta accreta 10.8
27 polyhydramnios 10.8
28 blood protein disease 10.8 MTHFR SERPINC1
29 ischemic colitis 10.8 APOH F5 SERPINC1
30 heparin-induced thrombocytopenia 10.8 F3 SERPINC1
31 pregnancy loss, recurrent 1 10.8 APOH F5
32 sneddon syndrome 10.8 APOH F5 SERPINC1
33 thrombasthenia 10.8 F3 F5 MTHFR
34 acquired hemophilia 10.8 F3 F5
35 gastroschisis 10.7 AFP IL6 MTHFR
36 homocysteinemia 10.7 F5 MTHFR SERPINC1
37 cerebral sinovenous thrombosis 10.7 APOH F3 F5
38 marantic endocarditis 10.7 F3 MTHFR SERPINC1
39 varicose veins 10.7 F5 MTHFR SERPINC1
40 sagittal sinus thrombosis 10.7 F3 F5 SERPINC1
41 diethylstilbestrol syndrome 10.7
42 sticky platelet syndrome 10.7 F5 SERPINC1
43 hepatitis a 10.7 AFP F3 SERPINC1
44 encephalomalacia 10.7 IL6 MTHFR SERPINH1
45 factor x deficiency 10.7 F3 F5 SERPINC1
46 homocystinuria 10.7 F5 MTHFR SERPINC1
47 disseminated intravascular coagulation 10.7 F3 F5 SERPINC1
48 hemorrhagic disease 10.6 F3 F5 SERPINC1
49 intermittent claudication 10.6 APOH IL6 SERPINC1
50 angina pectoris 10.6 F3 IL6 SERPINC1

Graphical network of the top 20 diseases related to Placenta Disease:



Diseases related to Placenta Disease

Symptoms & Phenotypes for Placenta Disease

UMLS symptoms related to Placenta Disease:


morning sickness, hyperemesis gravidarum, late pregnancy bleeding, maternal fever, intrapartum fever

GenomeRNAi Phenotypes related to Placenta Disease according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance GR00327-A 9.02 AFP CGB3 F5 MTHFR SERPINH1

MGI Mouse Phenotypes related to Placenta Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.85 PAPPA PGF SERPINC1 F3 SERPINH1 F5
2 growth/size/body region MP:0005378 9.73 PAPPA PGF PNLIP EPHA1 F3 SERPINH1
3 homeostasis/metabolism MP:0005376 9.5 PGF AFP APOH PNLIP EPHA1 SERPINC1

Drugs & Therapeutics for Placenta Disease

Drugs for Placenta Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 873)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 7440-66-6 23994
2
Copper Approved, Investigational Phase 4,Phase 3 7440-50-8 27099
3
Menthol Approved Phase 4,Phase 3,Phase 1,Not Applicable 2216-51-5 16666
4
Ampicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 69-53-4 6249
5
Labetalol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 36894-69-6 3869
6
Remifentanil Approved Phase 4,Phase 3,Phase 2,Phase 1 132875-61-7 60815
7
Amlodipine Approved Phase 4 88150-42-9 2162
8
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
9
Hydrocortisone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable,Early Phase 1 50-23-7 5754
10
Ranolazine Approved, Investigational Phase 4,Phase 2 142387-99-3, 95635-55-5 56959
11 Atosiban Approved, Investigational Phase 4,Phase 3,Phase 2 90779-69-4
12
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 2180-92-9, 38396-39-3 2474
13
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 9005-49-6 772 46507594
14
Iron Approved Phase 4,Phase 3,Phase 2,Not Applicable 7439-89-6 23925
15
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
16
Nifedipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 21829-25-4 4485
17
Azithromycin Approved Phase 4,Phase 2,Phase 3 83905-01-5 55185 447043
18
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
19
Clarithromycin Approved Phase 4,Phase 3 81103-11-9 84029
20
Carbetocin Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1,Not Applicable 37025-55-1 71715 16681432
21
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 299-42-3 9294
22
Methyldopa Approved Phase 4,Phase 2,Phase 1,Not Applicable 555-30-6 38853
23
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 90-82-4 7028
24
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
25
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 50-78-2 2244
26 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 979-32-8
27
Amiodarone Approved, Investigational Phase 4,Phase 3,Not Applicable 1951-25-3 2157
28
Phenylephrine Approved Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1 59-42-7 6041
29
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-83-0 5994
30
Mifepristone Approved, Investigational Phase 4,Phase 3,Not Applicable 84371-65-3 55245
31
Tranexamic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 1197-18-8 5526
32
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Not Applicable 10102-43-9 145068 160954
33
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
34
Calcium Carbonate Approved, Investigational Phase 4,Not Applicable 471-34-1
35
Sulfadoxine Approved, Investigational Phase 4,Phase 3,Not Applicable 2447-57-6 17134
36
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 103-90-2 1983
37
Citalopram Approved Phase 4,Early Phase 1,Not Applicable 59729-33-8 2771
38
Ergonovine Approved Phase 4,Phase 3,Not Applicable 60-79-7 443884
39
Ibuprofen Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 15687-27-1 3672
40
Metoclopramide Approved, Investigational Phase 4,Phase 3,Phase 2 364-62-5 4168
41
Pyrimethamine Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 58-14-0 4993
42
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 75614-87-8, 51-45-6 774
43
Isosorbide Dinitrate Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 87-33-2 6883
44
Cetrorelix Approved, Investigational Phase 4,Phase 2,Phase 3 120287-85-6 16129715 25074887
45
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable,Early Phase 1 1491-59-4 4636
46
Betamethasone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 378-44-9 9782
47
Indomethacin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 53-86-1 3715
48
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
49
Resveratrol Approved, Experimental, Investigational Phase 4 501-36-0 445154
50
Tinzaparin Approved Phase 4,Phase 3,Early Phase 1 9005-49-6, 9041-08-1 25244225

Interventional clinical trials:

(show top 50) (show all 3298)
# Name Status NCT ID Phase Drugs
1 Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria Unknown status NCT01636895 Phase 4 Efficacy of suphladoxine/pyrimethamine as IPTp;Efficacy of suphladoxine/pyrimethamine as IPTp
2 Remifentanil for General Anesthesia in Preeclamptics Unknown status NCT00567957 Phase 4 Remifentanil;Saline
3 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
4 Aspirin, Heparin and Miscarriage Unknown status NCT01917799 Phase 4 Aspirin;Heparin
5 Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia Unknown status NCT01718340 Phase 4 Metformin
6 Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical Trial Unknown status NCT01679561 Phase 4 intralipid
7 Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages Unknown status NCT01419392 Phase 4 Sildenafil citrate;matching placebo
8 Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment Unknown status NCT00256009 Phase 4 Cytotec
9 Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility Unknown status NCT00137982 Phase 4
10 Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial Unknown status NCT02342002 Phase 4 Mifepristone;Misoprostol
11 Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Acute Threatened Preterm Labour Unknown status NCT02068404 Phase 4 Nifedipine
12 Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Unknown status NCT01361425 Phase 4 methildopa;placebo
13 Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia Unknown status NCT00117546 Phase 4 alpha methyldopa
14 Oxytocin vs. Prostaglandin for Induction of Labor in Primiparas With Prelabor Rupture of Membrane and Low Bishop Unknown status NCT02801227 Phase 4 Oxytocin;Prostaglandin E2
15 The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth Unknown status NCT02571296 Phase 4 micronized progesterone;Placebo
16 Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation Unknown status NCT02353806 Phase 4 Amlodipine besylate
17 Low Dose Calcium to Prevent Preeclampsia Unknown status NCT02338687 Phase 4
18 Effects of Early Short-term Intravenous Iron Supplements Combinded EPO in Preterm Infants Unknown status NCT02060851 Phase 4 Iron sucrose;EPO
19 Hepatic Function and Bile Acid in Preterm Infants Receiving Parenteral Lipids Emulsion Unknown status NCT01786759 Phase 4 ClinOleic;Intralipid
20 Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants Unknown status NCT01683162 Phase 4 ClinOleic;Lipofundin;Intralipid
21 The Impact of Bryophyllum on Preterm Delivery Unknown status NCT00163579 Phase 4 Bryophyllum
22 Clindamycin Once a Day in Septic Abortion Unknown status NCT02309346 Phase 4 Clindamycin
23 Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial Unknown status NCT02590016 Phase 4 Insulin, Aspart
24 Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes Unknown status NCT00265746 Phase 4 Metformin
25 Oral Antidiabetic Agents in Pregnancy Unknown status NCT02091336 Phase 4 Metformin;Glyburide
26 Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women Unknown status NCT01511835 Phase 4 Folic Acid
27 Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding Unknown status NCT02853552 Phase 4 Misoprostol
28 PCC and Fibrinogen Compared With FFP in PPH Unknown status NCT01910675 Phase 4 PCC;FFP
29 Oxytocin in Cesarean Delivery Unknown status NCT01236482 Phase 4 Oxytocin versus oxytocin-ergometrine
30 Assessment of Implantation Potential of Embryos by Time-lapse Technology Unknown status NCT01760278 Phase 4 recombinant Follicle Stimulating Hormone (rFSH)
31 Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes? Unknown status NCT01997762 Phase 4
32 BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success Unknown status NCT01860690 Phase 4 Methotrexate
33 Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales Unknown status NCT02210702 Phase 4 Ethinyl Estradiol 35mcg/Norethindrone 1mg;Ethinyl Estradiol 20mcg/Norethindrone 1mg
34 ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery Unknown status NCT01579201 Phase 4 Carbetocin
35 Laparascopy Versus Laparatomy in the Management of Ruptured Ectopic Pregnancy Unknown status NCT01932957 Phase 4
36 To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats Unknown status NCT02319603 Phase 4 Low dose WenXin keli;High dose WenXin keli
37 Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates Unknown status NCT02179996 Phase 4
38 Study to Reduce Symptoms of Premature Beats With Ranolazine Unknown status NCT01996618 Phase 4 Ranolazine
39 Effects of ADSC Therapy in Women With POF Unknown status NCT01853501 Phase 4
40 Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Unknown status NCT01750775 Phase 4 Shensong Yangxin capsule;placebo Capsule
41 Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat Unknown status NCT01612260 Phase 4 Shensong Yangxin capsule;placebo Capsule
42 Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity Unknown status NCT00634972 Phase 4 ACULAR;REFRESH TEARS;placebo
43 Postpartum Oxygen Inhalation for the Treatment of Postpartum Haemorrhage Unknown status NCT01180192 Phase 4 oxygen
44 Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination Completed NCT02969447 Phase 4 Administration of 10 units of intra venous oxytocin after fetal expulsion
45 GOT-IT Trial: Glyceryl Trinitrate for Retained Placenta Completed NCT02085213 Phase 4 Glyceryl Trinitrate;Matched Placebo
46 Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study Completed NCT00707928 Phase 4 nitroglycerine
47 Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia Completed NCT00270530 Phase 4 Sulfadoxine-pyrimethamine (Fansidar)
48 Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Completed NCT01352234 Phase 4 Acetylsalicylic Acid;Acetylsalicylic Acid
49 Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW Completed NCT00190294 Phase 4 MIFEPRISTONE 200 mg and misoprostol 400 µg
50 Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment Completed NCT00746551 Phase 4 Ferli-6® (Continental Pharm co., ltd.);Venofer® (Vifor AG, St. Gallen, Switzerland)

Search NIH Clinical Center for Placenta Disease

Cochrane evidence based reviews: pregnancy complications

Genetic Tests for Placenta Disease

Anatomical Context for Placenta Disease

The Foundational Model of Anatomy Ontology organs/tissues related to Placenta Disease:

19
The Placenta

MalaCards organs/tissues related to Placenta Disease:

41
Placenta, Testes, Lung, Brain, Cervix, Endothelial, Heart

Publications for Placenta Disease

Articles related to Placenta Disease:

(show top 50) (show all 628)
# Title Authors Year
1
Liver ectopic pregnancy complicating a focal nodular hyperplasia. ( 29731143 )
2018
2
The occurrence and severity of intra-abdominal adhesions in cases of pregnancies complicated by placenta accreta: A case control study. ( 29902712 )
2018
3
Prenatal Diagnosis of Fragile X Syndrome in a Twin Pregnancy Complicated by a Complete Retraction. ( 29880767 )
2018
4
Prophylactic balloon occlusion of internal iliac arteries, common iliac arteries and infrarenal abdominal aorta in pregnancies complicated by placenta accreta: a retrospective cohort study. ( 29872910 )
2018
5
Inherited Thrombophilia and Pregnancy Complications: Should We Test? ( 29864774 )
2018
6
Pregnancy complicated by systemic lupus erythematosus and its outcome over 10 years. ( 29433371 )
2018
7
Ex Vivo Dual Perfusion of the Human Placenta: Disease Simulation, Therapeutic Pharmacokinetics and Analysis of Off-Target Effects. ( 29197003 )
2018
8
Unusual course of hyperreactio luteinalis in twin pregnancy complicated by twin to twin transfusion syndrome. ( 29363826 )
2018
9
Pregnancy complicated with PFAPA (periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis) syndrome: a case report. ( 29866074 )
2018
10
Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies. ( 29405972 )
2018
11
Successful management of a third-trimester pregnancy complicated by pheochromocytoma: case report. ( 29890868 )
2018
12
Management of pregnancy complicated with intracranial arteriovenous malformation. ( 29369471 )
2018
13
A case of twin IVF pregnancy complicated with sclerosing encapsulating peritonitis diagnosed at caesarean delivery. ( 29430973 )
2018
14
Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications. ( 28900802 )
2018
15
Evaluation of management and surgical outcomes in pregnancies complicated by acute cholecystitis. ( 29369817 )
2018
16
Twin pregnancy complicated by esophageal atresia, duodenal atresia, gastric perforation, and hypoplastic left heart structures in one twin: a case report and review of the literature. ( 28314387 )
2017
17
Amniotic fluid clusterin in pregnancies complicated by the preterm prelabor rupture of membranes. ( 27806672 )
2017
18
Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy. ( 28791262 )
2017
19
Histologic chorioamnionitis does not modulate the oxidative stress and antioxidant status in pregnancies complicated by spontaneous preterm delivery. ( 29132320 )
2017
20
Outcomes of twin pregnancies complicated by gestational diabetes: a meta-analysis of observational studies. ( 28079866 )
2017
21
Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study. ( 28350837 )
2017
22
Re: Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia. R. Orabona, E. Sciatti, E. Vizzardi, I. Bonadei and A. Valcamonico. Ultrasound Obstet Gynecol 2017; 49: 116-123. ( 28058790 )
2017
23
Measurement and evaluation of fetal fat layer in the prediction of fetal macrosomia in pregnancies complicated by gestational diabetes. ( 28631075 )
2017
24
[Macroscopic description of placental vascular anastomoses after dye injection for the comprehension of monochorionic pregnancy complications]. ( 28479073 )
2017
25
Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications. ( 28361296 )
2017
26
Pre-pregnancy and Early Prenatal Care are Associated with Lower Risk of Ectopic Pregnancy Complications in the Medicaid Population: 2004-08. ( 27859439 )
2017
27
Clinical analysis: 13 cases of pregnancy complicated with Takayasu arteritis. ( 29303222 )
2017
28
Expression of EGF, EGFR, and proliferation in placentas from pregnancies complicated with preeclampsia. ( 27657362 )
2017
29
Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios. ( 28643663 )
2017
30
Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia: Continuous Versus Cutoff Values. ( 28847893 )
2017
31
Prophylactic use of an infrarenal abdominal aorta balloon catheter in pregnancies complicated by placenta accreta. ( 28366073 )
2017
32
The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-I^ in Pregnancy Complicated by Placental Insufficiency. ( 28698875 )
2017
33
Lower placental growth factor and higher free I^-hCG and PAPP-A levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia. ( 27809614 )
2017
34
Reduced expression of follicle stimulating hormone receptor mRNA and protein in pregnancies complicated by prea89eclampsia. ( 28534997 )
2017
35
Iliac artery balloon catheter use in abnormally invasive placenta disease management - a reply. ( 29047135 )
2017
36
Perinatal outcome in singleton pregnancies complicated with preeclampsia and eclampsia in Ecuador. ( 26790539 )
2016
37
Prenatal ultrasound factors and genetic disorders in pregnancies complicated by polyhydramnios. ( 27247190 )
2016
38
Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a). ( 26827667 )
2016
39
Bipolar cord coagulation for selective feticide in a monochorionic twin pregnancy complicated by pentalogy of Cantrell. ( 26927267 )
2016
40
Re: Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early or late pre-eclampsia. R. Orabona, C. M. Donzelli, M. Falchetti, A. Santoro, A. Valcamonico and T. Frusca. Ultrasound Obstet Gynecol 2016; 47: 580-585. ( 27147413 )
2016
41
The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome. ( 27401656 )
2016
42
Spontaneous Rectus Sheath Hematoma in Pregnancy Complicated by the Development of Transfusion Related Acute Lung Injury: A Case Report and Review of the Literature. ( 27651980 )
2016
43
Placental microRNA expression in pregnancies complicated by superimposed prea89eclampsia on chronic hypertension. ( 27176897 )
2016
44
Pregnancies Complicated by Hemoglobin H disease. ( 27799984 )
2016
45
Maternal serum thiol/disulfide homeostasis in pregnancies complicated by neural tube defects: report of a preliminary study. ( 27546170 )
2016
46
Cervical Ectopic Pregnancy Complicated by Escherichia Coli Septicemia: A Case Report. ( 27106199 )
2016
47
Pregnancy complications in spontaneous and assisted conceptions of women with infertility and subfertility factors. A comprehensive review. ( 27591135 )
2016
48
Perinatal Management of Pregnancy Complicated by Autosomal Dominant Emery-Dreifuss Muscular Dystrophy. ( 27054045 )
2016
49
Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsia. ( 26321036 )
2016
50
Prospective assessment of neurodevelopment in children following a pregnancy complicated by severe pre-eclampsia. ( 27388354 )
2016